Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-21-069350

President & CEO bought 53,634 shares at an average $3.71 ($198,972)

From the SEC's structured data for this filing

Trades in this filing

Quinn Anthony G. · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-09 Purchase : show line 1 in the form +43,108 $3.70 $159,500 318,269 D
2021-12-10 Purchase : show line 2 in the form +10,526 $3.75 $39,473 328,795 D
Open-market purchases · 53,634 sh · avg $3.71 · $198,972
Loading xslF345X03/doc4.xml…